Both in Pharmaceuticals
Corcept Therapeutics vs BridgeBio Pharma
Over the past year CORT returned +36.8% and BBIO returned +27.0%; their daily moves had a correlation of 0.13.
CORT +36.8% BBIO +27.0%Growth of $1, one year, split-adjusted
| Metric | CORT | BBIO |
|---|---|---|
| Price | $114.74 | $65.97 |
| Market cap | $12.40B | $12.90B |
| Today | −0.77% | −0.96% |
| 1 month | +0.8% | −13.9% |
| 6 months | +201.0% | −4.9% |
| Year to date | +229.7% | −13.8% |
| 1 year | +36.8% | +31.8% |
| Revenue growth (YoY) | +31.7% | +120.4% |
| Gross margin | 98.4% | 93.8% |
| Net margin | 16.8% | −62.5% |
| P/E (TTM) | 227.6× | — |
| Price / sales | 14.9× | 18.1× |
| Net cash | $308.2M | -$1.76B |
| Dividend yield | — | — |
| Volatility (60d) | 64.4% | 42.8% |
| Short % of float | 9.8% | 13.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).